Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Brain Neoplasms × Gemcitabine × Clear all

Phase

Phase 1 2 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 87 Neoplasms 26 Carcinoma, Non-Small-Cell Lung 25 Neoplasm Metastasis 20 Urinary Bladder Neoplasms 15 Colorectal Neoplasms 13 Sarcoma 12 Lymphoma, Large B-Cell, Diffuse 11 Lung Neoplasms 11 Breast Neoplasms 11 Biliary Tract Neoplasms 11 Ovarian Neoplasms 9 Lymphoma 9 Recurrence 7 Hodgkin Disease 7 Cholangiocarcinoma 7 Carcinoma, Transitional Cell 7 Non-Muscle Invasive Bladder Neoplasms 6 Lymphoma, Non-Hodgkin 6 Lymphoma, Follicular 6 Adenocarcinoma 6 Small Cell Lung Carcinoma 5 Gastrointestinal Neoplasms 5 Triple Negative Breast Neoplasms 4 Stomach Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Advanced Solid Tumor 4 Urethral Neoplasms 3 Rectal Neoplasms 3 Prostatic Neoplasms 3

Interventions

Temozolomide 24 Radiosurgery 12 Bevacizumab 12 Radiotherapy 8 Carboplatin 8 pembrolizumab 7 Trastuzumab 6 Erlotinib Hydrochloride 5 abemaciclib 4 Paclitaxel 4 Irinotecan 4 Capecitabine 4 tipifarnib 3 temsirolimus 3 Sirolimus 3 Radiation 3 Mental Status and Dementia Tests 3 Ipilimumab 3 Everolimus 3 Aminolevulinic Acid 3 tucatinib 2 pertuzumab 2 fludarabine 2 durvalumab 2 alovudine 2 Vorinostat 2 Surgical Procedures, Operative 2 Sorafenib 2 Nivolumab 2 NVP-BKM120 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04711824 2025-12-23

SOLARA

Hoosier Cancer Research Network

Phase 1/2 Recruiting

Brain Neoplasms, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡